文献速递产科母胎医学

全国范围内对持续妊娠应用全基因组测序五年:诊断率、时效与实施情况

Five years of nationwide use of whole genome sequencing in ongoing pregnancies: Diagnostic yield, timing, and implementation
RSS 订阅 · Acta Obstetricia et Gynecologica Scandinavica · 2026-11-11

丹麦2019至2023年对207例染色体微阵列正常的单胎妊娠行产前全基因组测序,33例(15.9%)检出可解释表型的致病或可能致病变异,持续妊娠中位周转时间11个工作日,二次发现18例(8.7%)。

要点

  • 染色体微阵列正常后行产前全基因组测序,诊断率15.9%(95%CI 11.6–21.5)。
  • 水肿胎儿诊断率最高(25.0%),多发畸形24.3%,孤立性颈项透明层增厚最低(7.1%)。
  • 持续妊娠中位周转时间11个工作日,二次发现报告率8.7%。

核心结论

  • 产前全基因组测序可在临床相关周转时间内完成,在染色体微阵列阴性人群中提供增量诊断价值。
  • 临床实践中,正常和异常的产前全基因组测序结果均为持续妊娠中胎儿风险未明时咨询的核心组成部分。
  • 本研究未评估此类结果对父母决策或妊娠结局的影响。

研究设计与样本

  • 历史性队列研究,纳入2019至2023年在丹麦四个临床遗传学实验室所有染色体微阵列正常后行产前全基因组测序的单胎妊娠。
  • 共分析207例,其中绒毛膜绒毛样本85例、羊水样本122例;204/207(98.6%)行家系三人测序。
  • 从四个丹麦临床遗传学实验室提取样本类型、开单时孕周、周转时间、诊断率及二次发现数据。

主要发现

  • 开单时中位孕周为20周(IQR 17–21)。
  • 持续妊娠中位周转时间为11个工作日(IQR 8–17)。
  • 33/207例(15.9%,95%CI 11.6–21.5)检出可解释表型的致病或可能致病变异。
  • 诊断率在水肿胎儿中最高(25.0%,95%CI 12.0–44.9),多发畸形为24.3%(95%CI 13.4–40.1),孤立性颈项透明层增厚最低(7.1%,95%CI 2.0–22.6)。
  • 二次发现报告18/207例(8.7%,95%CI 5.6–13.3)。

临床怎么用

  • 作者指出,临床实践中正常和异常的产前全基因组测序结果均为持续妊娠中胎儿风险未明时咨询的核心组成部分。

局限性

  • 本研究未评估产前全基因组测序结果对父母决策或妊娠结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Denmark, prenatal whole genome sequencing was performed in 207 pregnancies after a normal chromosomal microarray between 2019 and 2023. A pathogenic or likely pathogenic variant explaining the fetal phenotype was identified in 33 cases (15.9%). Among 189 pregnancies intended to continue, the median turnaround time was 11 working days. Abstract Introduction We describe timing, diagnostic yield, secondary findings of prenatal whole genome sequencing (pWGS) in ongoing pregnancies during the first 5 years of implementation within a publicly funded healthcare system. Moreover, we discuss our collective clinical experiences implementing pWGS in prenatal care. Material and Methods We conducted a historical cohort study, including all singleton pregnancies undergoing pWGS after a normal chromosomal microarray between 2019 and 2023. Data on sample type, gestational age at test ordering, turnaround time, diagnostic yield, and secondary findings were extracted from all four Danish clinical genetics laboratories. Results A total of 207 cases were analyzed, including 85 chorionic villus samples and 122 amniotic fluid samples; trio sequencing was performed in 204/207 (98.6%). Median gestational age at ordering was 20 weeks (IQR 17–21). Median turnaround time for ongoing pregnancies was 11 working days (IQR 8–17). Pathogenic or likely pathogenic variants explaining the phenotype were identified in 33/207 pregnancies (15.9%, 95% CI 11.6–21.5). Yield was highest in hydrops (25.0%, 95% CI 12.0–44.9) and multiple anomalies (24.3%, 95% CI 13.4–40.1), and lowest in isolated increased nuchal translucency (7.1%, 95% CI 2.0–22.6). Secondary findings were reported in 18/207 cases (8.7%, 95% CI 5.6–13.3). Conclusions pWGS was delivered within clinically relevant turnaround times. Applied after normal chromosomal microarray, the yield represents incremental diagnostic value in a chromosomal microarray-negative population. In clinical practice, both normal and abnormal pWGS results form a central component of counseling in ongoing pregnancies with unresolved fetal risk. However, the impact of such results on parental decision-making or pregnancy outcomes was not assessed in this study.

来源:Acta Obstetricia et Gynecologica Scandinavica,查看原文。版权归原作者所有。

引用

  1. Acta Obstetricia et Gynecologica Scandinavica:Five years of nationwide use of whole genome sequencing in ongoing pregnancies: Diagnostic yield, timing, and implementation

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。